DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slumped 0.84% to $55.36 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.16% to 5,836.22 and the Dow Jones Industrial Average rising 0.86% to 42,297.12.
This was the stock's third consecutive day of losses.
Bristol Myers Squibb Co. closed $5.72 below its 52-week high ($61.08), which the company achieved on November 11th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.70% to $144.47, Pfizer Inc. $(PFE)$ rose 0.30% to $26.80, and Abbott Laboratories $(ABT)$ rose 0.78% to $113.19.
Trading volume (6.8 M) remained 4.5 million below its 50-day average volume of 11.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 13, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 13, 2025 16:40 ET (21:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.